{"id":9195,"date":"2023-11-03T11:34:00","date_gmt":"2023-11-03T10:34:00","guid":{"rendered":"http:\/\/cilcare.com\/?page_id=9195"},"modified":"2025-05-14T19:00:12","modified_gmt":"2025-05-14T17:00:12","slug":"pk-distribution","status":"publish","type":"page","link":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/pk-distribution\/","title":{"rendered":"\u5185\u8033\u306b\u304a\u3051\u308b\u85ac\u7269\u52d5\u614b\uff08PK\uff09\u8a66\u9a13"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"9195\" class=\"elementor elementor-9195\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1297866 e-flex e-con-boxed e-con e-parent\" data-id=\"1297866\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a631965 elementor-widget elementor-widget-heading\" data-id=\"a631965\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">\u5185\u8033\u306b\u304a\u3051\u308b\u85ac\u7269\u52d5\u614b\uff08PK\uff09\u8a66\u9a13<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1310c05 e-flex e-con-boxed e-con e-parent\" data-id=\"1310c05\" data-element_type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f694281 elementor-invisible elementor-widget elementor-widget-text-editor\" data-id=\"f694281\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>.elementor-element-f694281{display:none !important}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5eabd0b elementor-invisible elementor-widget elementor-widget-text-editor\" data-id=\"5eabd0b\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"translation-block\">\u6295\u4e0e\u7d4c\u8def\u306b\u95a2\u308f\u3089\u305a\u3001\u96e3\u8074\u307e\u305f\u306f\u8033\u9cf4\u308a\u306e\u85ac\u5264\u5019\u88dc\u306f\u3001\u76ee\u7684\u306e\u6fc3\u5ea6\u3067\u6a19\u7684\u3067\u3042\u308b\u5185\u8033\u306b\u5230\u9054\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u30b7\u30eb\u30b1\u30a2\u306e\u85ac\u7269\u52d5\u614b\u8a66\u9a13\u3067\u306f\u3001\u5185\u8033\u306b\u304a\u3051\u308b\u5019\u88dc\u7269\u8cea\u306e\u30d0\u30a4\u30aa\u30a2\u30d9\u30a4\u30e9\u30d3\u30ea\u30c6\u30a3\u3092\u8a55\u4fa1\u3057\u3001\u305d\u306e\u52d5\u614b\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6c7a\u5b9a\u3057\u3001\u305d\u306e\u5f8c\u306e\u6709\u52b9\u6027\u8a66\u9a13\u306b\u304a\u3051\u308b\u6700\u9069\u306a\u6295\u4e0e\u6642\u70b9\u3068\u6fc3\u5ea6\u3092\u63a8\u5b9a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\uff1a<\/p><ul><li class=\"translation-block\">\u6295\u4e0e\u7d4c\u8def\uff1a\u5c40\u6240\uff08\u9f13\u819c\u7d4c\u7531\u3001\u9f13\u80de\u5185\u3001\u8778\u725b\u5185\u3001\u6b63\u5186\u7a93\u30cb\u30c3\u30c1\uff09\u304a\u3088\u3073\u5168\u8eab\uff08\u7d4c\u53e3\u3001\u8179\u8154\u5185\u3001\u9759\u8108\u5185\u3001\u76ae\u4e0b\u3001\u7b4b\u8089\u5185\uff09<\/li><li class=\"translation-block\">\u5358\u56de\u6295\u4e0e\uff08\u6ce8\u5c04\u307e\u305f\u306f\u70b9\u6ef4\uff09\u3001\u307e\u305f\u306f\u53cd\u5fa9\u6295\u4e0e\u5f8c\u306e\u52d5\u614b<\/li><li class=\"translation-block\">\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\uff1a\u5185\u8033\u6db2\u3001\u9f13\u5ba4\u80de\u3001\u8133\u810a\u9ac4\u6db2\uff08CSF\uff09\u3001\u5404\u7a2e\u8133\u9818\u57df\u3001\u8840\u6db2\u304a\u3088\u3073\u8840\u6f3f<\/li><li><strong>\u751f\u7269\u5b66\u7684\u30b5\u30f3\u30d7\u30eb\u306b\u95a2\u3059\u308b\u751f\u7269\u5206\u6790\u30c7\u30fc\u30bf*\uff1a<\/strong><ul><li>\u63a2\u7d22\u7684LC-MS\/MS\u5206\u6790\uff08\u4f4e\u5206\u5b50\uff09<\/li><li>ELISA\u30a2\u30c3\u30bb\u30a4\u3001\u5e02\u8ca9\u307e\u305f\u306f\u30ab\u30b9\u30bf\u30de\u30a4\u30ba<\/li><li>\u5185\u8033\u6db2\u304a\u3088\u3073\u9f13\u5ba4\u80de\u7d44\u7e54\u306e\u51e6\u7406\u306b\u304a\u3051\u308b\u5c02\u9580\u77e5\u8b58<\/li><\/ul><\/li><\/ul><p><em>*\u30b7\u30eb\u30b1\u30a2\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u4f01\u696d\u304c\u5b9f\u65bd<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>inner ear PK studies Whatever the route of administration, the drug candidate for hearing loss or tinnitus has to reach its target, the inner ear, at the desired concentration. Cilcare\u2019s PK studies allow the assessment of the bioavailability of the candidate in the inner ear, to determine its kinetic profile, and to estimate the best time-point and concentration for dosing in a subsequent efficacy study: Route of administration: local (transtympanic, intrabullar, intracochlear, round window niche) and systemic (PO, IP, IV, SC, IM) Kinetics after single (injection or infusion), or repeated administration Samplings: inner ear fluid, tympanic bulla, cerebrospinal fluid (CSF), different brain structures, blood &amp; plasma Bioanalytical data on biological [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"parent":9055,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9195","page","type-page","status-publish","hentry","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>inner ear PK studies - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/pk-distribution\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"inner ear PK studies - Cilcare\" \/>\n<meta property=\"og:description\" content=\"inner ear PK studies Whatever the route of administration, the drug candidate for hearing loss or tinnitus has to reach its target, the inner ear, at the desired concentration. Cilcare\u2019s PK studies allow the assessment of the bioavailability of the candidate in the inner ear, to determine its kinetic profile, and to estimate the best time-point and concentration for dosing in a subsequent efficacy study: Route of administration: local (transtympanic, intrabullar, intracochlear, round window niche) and systemic (PO, IP, IV, SC, IM) Kinetics after single (injection or infusion), or repeated administration Samplings: inner ear fluid, tympanic bulla, cerebrospinal fluid (CSF), different brain structures, blood &amp; plasma Bioanalytical data on biological [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/pk-distribution\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-14T17:00:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/\",\"url\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/\",\"name\":\"inner ear PK studies - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"datePublished\":\"2023-11-03T10:34:00+00:00\",\"dateModified\":\"2025-05-14T17:00:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our missions &#8211; External innovation\",\"item\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"inner ear PK studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"inner ear PK studies - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/pk-distribution\/","og_locale":"ja_JP","og_type":"article","og_title":"inner ear PK studies - Cilcare","og_description":"inner ear PK studies Whatever the route of administration, the drug candidate for hearing loss or tinnitus has to reach its target, the inner ear, at the desired concentration. Cilcare\u2019s PK studies allow the assessment of the bioavailability of the candidate in the inner ear, to determine its kinetic profile, and to estimate the best time-point and concentration for dosing in a subsequent efficacy study: Route of administration: local (transtympanic, intrabullar, intracochlear, round window niche) and systemic (PO, IP, IV, SC, IM) Kinetics after single (injection or infusion), or repeated administration Samplings: inner ear fluid, tympanic bulla, cerebrospinal fluid (CSF), different brain structures, blood &amp; plasma Bioanalytical data on biological [&hellip;]","og_url":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/pk-distribution\/","og_site_name":"Cilcare","article_modified_time":"2025-05-14T17:00:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/","url":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/","name":"inner ear PK studies - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"datePublished":"2023-11-03T10:34:00+00:00","dateModified":"2025-05-14T17:00:12+00:00","breadcrumb":{"@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/pk-distribution\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Our missions &#8211; External innovation","item":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/"},{"@type":"ListItem","position":3,"name":"inner ear PK studies"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/9195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=9195"}],"version-history":[{"count":130,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/9195\/revisions"}],"predecessor-version":[{"id":13650,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/9195\/revisions\/13650"}],"up":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/9055"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=9195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}